Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Urologic Health Inc. raises $11M in seed funding, led by an undisclosed strategic investor and supported by Edge Medical Ventures, SHD Partners, and Longevity Venture Partners.
PRIVATEMay 14, 2026•3 months ago
Amount Raised
$11 Million
Round Type
Seed
Investors
Longevity Venture PartnersShd PartnersEdge Medical VenturesUndisclosed Strategic Investor
Description
Urologic Health Inc., based in Jersey City, New Jersey and Or Yehuda, Israel, has raised $11M in seed funding. The company will use the funds for clinical validation, product development, and regulatory support. Investors include Edge Medical Ventures, SHD Partners, and Longevity Venture Partners. The goal is to advance its non-invasive urodynamic testing platform, the niu™ System.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech